LXRα, ABCA1, and ABCG1 were negatively associated with ALT levels, which is related to lipid metabolism and obesity and reflects hepatocellular injury in patients with NAFLD [40,41]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.